JP2000501093A - β―インターフェロンを使用して再狭窄を治療する方法 - Google Patents
β―インターフェロンを使用して再狭窄を治療する方法Info
- Publication number
- JP2000501093A JP2000501093A JP9520329A JP52032997A JP2000501093A JP 2000501093 A JP2000501093 A JP 2000501093A JP 9520329 A JP9520329 A JP 9520329A JP 52032997 A JP52032997 A JP 52032997A JP 2000501093 A JP2000501093 A JP 2000501093A
- Authority
- JP
- Japan
- Prior art keywords
- interferon
- human
- coronary artery
- cells
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.治療に有効な量のヒトインターフェロン−βをこれが必要な人間に投与する ことを特徴とする、再狭窄を治療する方法。 2.再狭窄が冠状動脈内に存在する、請求の範囲1記載の方法。 3.ヒトインターフェロン−βが、インターフェロン−βser17である、請求の 範囲1記載の方法。 4.ヒトインターフェロン−βが血管形成術、血管内膜切除術または動脈切除術 に続く血管障害の位置の冠状動脈平滑筋細胞の増殖を阻止することに選択的であ る、請求の範囲1記載の方法。 5.治療に有効な量のインターフェロン−βser17をこれが必要な人間に投与し 、この場合にインターフェロン−βser17が冠状動脈平滑筋細胞の増殖を阻止し 、同時に冠状動脈内皮細胞の増殖の阻止作用を有しないことを特徴とする、冠状 動脈の再狭窄を治療する方法。 6.生体外または生体内でヒトインターフェロン−βを投与することにより、ヒ ト冠状動脈平滑筋細胞の増殖を阻止し、同時に冠状動脈内皮細胞の増殖の阻止作 用を有しない方法。 7.ヒトインターフェロン−βが、インターフェロン−βser17である、請求の 範囲6記載の方法。 8.再狭窄を治療する薬剤の製造へのヒトインターフェロン−βの使用。 9.再狭窄が冠状動脈内に存在する、請求の範囲8記載の使用。 10.ヒトインターフェロン−βが、インターフェロン−βser17である、請求 の範囲8記載の使用。 11.ヒトインターフェロン−βが血管形成術、血管内膜切除術または動脈切除 術に続く血管障害の位置の冠状動脈平滑筋細胞の増殖を阻止することに選択的で ある、請求の範囲8記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/565,701 | 1995-11-30 | ||
US08/565,701 US5681558A (en) | 1995-11-30 | 1995-11-30 | Method of using beta-interferons to treat restenosis |
PCT/IB1996/001468 WO1997019697A1 (en) | 1995-11-30 | 1996-11-28 | Method of using beta-interferons to treat restenosis |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007264701A Division JP2008031179A (ja) | 1995-11-30 | 2007-10-10 | β−インターフェロンを使用して再狭窄を治療する方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000501093A true JP2000501093A (ja) | 2000-02-02 |
JP4116075B2 JP4116075B2 (ja) | 2008-07-09 |
Family
ID=24259751
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52032997A Expired - Lifetime JP4116075B2 (ja) | 1995-11-30 | 1996-11-28 | β―インターフェロンを使用して再狭窄を治療する方法 |
JP2007264701A Pending JP2008031179A (ja) | 1995-11-30 | 2007-10-10 | β−インターフェロンを使用して再狭窄を治療する方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007264701A Pending JP2008031179A (ja) | 1995-11-30 | 2007-10-10 | β−インターフェロンを使用して再狭窄を治療する方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5681558A (ja) |
EP (1) | EP0869813B1 (ja) |
JP (2) | JP4116075B2 (ja) |
AT (1) | ATE303158T1 (ja) |
AU (1) | AU712960B2 (ja) |
CA (1) | CA2238871C (ja) |
DE (1) | DE69635131T2 (ja) |
DK (1) | DK0869813T3 (ja) |
ES (1) | ES2247607T3 (ja) |
WO (1) | WO1997019697A1 (ja) |
ZA (1) | ZA9610073B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866561A (en) * | 1997-08-21 | 1999-02-02 | Scimed Life Systems, Inc. | Local delivery of estrogen for angiogenesis |
US6537195B2 (en) | 2001-05-07 | 2003-03-25 | Xoft, Microtube, Inc. | Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia |
US7041046B2 (en) * | 2001-05-07 | 2006-05-09 | Xoft, Inc. | Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia |
US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4992271A (en) * | 1982-09-23 | 1991-02-12 | Cetus Corporation | Formulation for lipophilic IL-2 proteins |
US4462940A (en) * | 1982-09-23 | 1984-07-31 | Cetus Corporation | Process for the recovery of human β-interferon-like polypeptides |
US4588585A (en) * | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
SE462364B (sv) * | 1988-09-30 | 1990-06-18 | Goeran Hansson | Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos |
JPH04116075A (ja) * | 1990-09-03 | 1992-04-16 | Hitachi Building Syst Eng & Service Co Ltd | エレベータの乗り場報知装置 |
AU685080B2 (en) * | 1993-01-07 | 1998-01-15 | Thomas Jefferson University | Antisense inhibition of C-MYC to modulate the proliferation of smooth muscle cells |
US6780406B1 (en) * | 1994-03-21 | 2004-08-24 | The Regents Of The University Of Michigan | Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
WO1997018831A1 (fr) * | 1995-11-17 | 1997-05-29 | Toray Industries, Inc. | Protection des cellules endotheliales |
-
1995
- 1995-11-30 US US08/565,701 patent/US5681558A/en not_active Expired - Lifetime
-
1996
- 1996-11-28 AT AT96940704T patent/ATE303158T1/de not_active IP Right Cessation
- 1996-11-28 WO PCT/IB1996/001468 patent/WO1997019697A1/en active IP Right Grant
- 1996-11-28 DK DK96940704T patent/DK0869813T3/da active
- 1996-11-28 AU AU10703/97A patent/AU712960B2/en not_active Ceased
- 1996-11-28 ES ES96940704T patent/ES2247607T3/es not_active Expired - Lifetime
- 1996-11-28 DE DE69635131T patent/DE69635131T2/de not_active Expired - Lifetime
- 1996-11-28 JP JP52032997A patent/JP4116075B2/ja not_active Expired - Lifetime
- 1996-11-28 EP EP96940704A patent/EP0869813B1/en not_active Expired - Lifetime
- 1996-11-28 CA CA002238871A patent/CA2238871C/en not_active Expired - Lifetime
- 1996-11-29 ZA ZA9610073A patent/ZA9610073B/xx unknown
-
2007
- 2007-10-10 JP JP2007264701A patent/JP2008031179A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ATE303158T1 (de) | 2005-09-15 |
DK0869813T3 (da) | 2006-01-02 |
ZA9610073B (en) | 1997-06-18 |
DE69635131T2 (de) | 2006-07-06 |
DE69635131D1 (de) | 2005-10-06 |
WO1997019697A1 (en) | 1997-06-05 |
JP2008031179A (ja) | 2008-02-14 |
US5681558A (en) | 1997-10-28 |
CA2238871A1 (en) | 1997-06-05 |
ES2247607T3 (es) | 2006-03-01 |
EP0869813A4 (en) | 2003-02-05 |
AU1070397A (en) | 1997-06-19 |
CA2238871C (en) | 2006-08-15 |
AU712960B2 (en) | 1999-11-18 |
JP4116075B2 (ja) | 2008-07-09 |
EP0869813A1 (en) | 1998-10-14 |
EP0869813B1 (en) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Granstein et al. | A controlled trial of intralesional recombinant interferon-? in the treatment of keloidal scarring: clinical and histologic findings | |
Palladino Jr et al. | Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity. | |
Wong et al. | Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1 | |
Peterson et al. | Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. | |
DE69333321T3 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
US6045788A (en) | Method of stimulation of immune response with low doses of IL-2 | |
Heidenreich et al. | Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. | |
US5318957A (en) | Method of stimulating angiogenesis | |
Heyns et al. | The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events: Studies with vascular smooth muscle cells and endothelial cells | |
DE69213744D1 (de) | Verabreichung von antisensen oligonukleotiden und peptiden als arzeneimittel an geweben in vivo und an zellen durch verwendung von avidin-biotin-technologie | |
Stemme et al. | MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin. | |
EP2298310A3 (en) | Therapeutic inhibitors of vascular smooth muscle cells | |
Goureau et al. | Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retinal pigmented epithelial cells | |
JPH0653676B2 (ja) | インターフェロンの相乗効果 | |
Ballas | Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclophosphamide. | |
Bresalier et al. | The laminin α1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells | |
JP2008031179A (ja) | β−インターフェロンを使用して再狭窄を治療する方法 | |
JPH10502371A (ja) | リンホトキシンを用いる癌処置法 | |
JP2784401B2 (ja) | 慢性骨髄性白血病の治療方法 | |
Keith et al. | The effect of diphenylhydantoin on fibroblasts in vitro | |
Borden et al. | Preclinical and clinical studies of interferons and interferon inducers in breast cancer | |
CA2069870E (en) | Treatment of atopic disorders with gamma-interferon | |
Mageed et al. | Natural killer cells in children with acute leukemia. The effect of interleukin‐2 | |
Castronuovo Jr et al. | Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by gamma-interferon | |
Johns et al. | Pharmacokinetics, tissue distribution, and cell localization of [35S] methionine-labeled recombinant human and murine α interferons in mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070214 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070612 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071010 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20071101 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080319 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080417 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110425 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110425 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120425 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120425 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120425 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120425 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120425 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120425 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130425 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130425 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140425 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |